Cuisinart Outdoors® Unveils Two New Revolutionary Grills with Industry-First Technology
STAMFORD, Conn., Feb. 27, 2025 /PRNewswire/ -- Cuisinart Outdoors®, a brand dedicated to enhancing outdoor experiences with innovative culinary and comfort solutions, is introducing two game-changing grills each featuring pioneering technology. The 28" Outdoor Griddler™- 2-in-1 Griddle & Broiler and the Propel+ Four Burner 3-in-1 Gas Grill (Grill, Griddle, Pizza Oven) will be available at national retailers starting March 1.
'At Cuisinart Outdoors, our goal is to elevate and simplify the entire outdoor entertaining experience,' said Kris Kahn, SVP & General Manager for Cuisinart Outdoors, a division of Conair LLC. 'The Propel+ Four Burner 3-in-1 Gas Grill and the 28" Outdoor Griddler™- 2-in-1 Griddle & Broiler do just that. By bringing professional-grade technology and versatile features to outdoor cooking, they're truly a one stop shop made for backyard chefs of all levels.'
The demand for multifunctional outdoor cooking spaces has never been higher and these new offerings may just ignite a battle of the barbeques among grillers in backyards across the country. Both grills are designed with first-of-their-kind technology and innovative features like a patent-pending contour lid and baffle system, making them all-in-one solutions that can cook up breakfast, lunch and dinner, making outdoor cooking professional level meals practical and easy.
28" Outdoor Griddler™- 2-in-1 Griddle & Broiler: Seamlessly transition between griddling and broiling with the first-ever 2-in-1 Griddle & Broiler, delivering unmatched versatility. The patent-pending Broiler Baffles system controls heat with precision—locking it in for high-heat searing or releasing it for toasting and warming. A spacious 504 sq. in. griddle handles everything from pancakes to burgers, while the adjustable 3-level broiler ensures a perfect flame-kissed finish on steaks, veggies, and more. Sleek, modern, and powerful, this all-in-one outdoor essential is redefining backyard cooking.
Cuisinart Propel+ Four Burner 3-in-1 Gas Grill (Grill, Griddle, Pizza Oven): Built for today's multi-tasking griller, its patent-pending contour lid creates Thermo-Flo™ technology that ensures rapid preheating and even heat distribution across the cooking surface. With nearly 500 square inches of cooking space, this grill also has a premium griddle and 15" pizza stone perfect for making restaurant quality pizza in under six minutes.
Home cooks will be able to shop for the new grills at nationwide retailers like The Home Depot, Best Buy, and Amazon at an SRP of $499.99. Cuisinart will unveil these groundbreaking products at The Inspired Home Show (March 2-4) and the National Hardware Show (March 18-20), where industry experts and attendees will experience their versatility firsthand.
For more information, please visit www.cuisinart.com/shopping/outdoors.
Connect with Cuisinart Outdoors:
TikTok
ABOUT CUISINART OUTDOORS:
Cuisinart is a premier kitchenware brand dedicated to making culinary experiences enjoyable and accessible for home cooks everywhere. Established in 1973, Cuisinart revolutionized the way food is prepared with the introduction of the food processor and has continued to innovate ever since. Expanding beyond the kitchen, Cuisinart Outdoors brings the same commitment to quality, functionality, and style to outdoor cooking and entertainment. From high-performance grills to versatile accessories and heating solutions, Cuisinart Outdoors is redefining how people cook, entertain, and enjoy their outdoor spaces year-round. Passionate about bringing people together through food, Cuisinart fosters connections and enhances the joy of cooking. Whether indoors or out, their products empower cooks of all levels to unleash their culinary potential and create memorable meals for family and friends.
Press Contacts
Zeno Group
Ashley Friedman
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
13 minutes ago
- Business Upturn
Aurobindo Pharma's subsidiary CuraTeQ Biologics secures marketing approval for trastuzumab biosimilar ‘Dazublys'
Aurobindo Pharma's wholly owned step-down subsidiary, CuraTeQ Biologics s.r.o., has achieved a major milestone with the European Commission granting marketing authorization for Dazublys™, its trastuzumab biosimilar. This approval follows the positive opinion issued by the European Medicines Agency's (EMA) CHMP in April 2025, recommending the product for authorization. Dazublys™ is a biosimilar of trastuzumab, a widely used monoclonal antibody in the treatment of HER2-positive breast and gastric cancers. With this latest approval, Dazublys™ becomes CuraTeQ's third EMA-approved biosimilar, following Dyrupeg™ (approved in April 2025) and Zefylti™ (approved in February 2025). It also marks the fourth biosimilar approval for CuraTeQ in the European region, including Bevqolva™, which received a green light from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) in December 2024. This continued string of regulatory successes further strengthens Aurobindo Pharma's global biosimilar portfolio and underscores the company's commitment to expanding access to high-quality, affordable biologics in key regulated markets. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
29 minutes ago
- Yahoo
KellyOCG + Sevenstep Named RPO Leader, Star Performer by Everest Group
Kelly's permanent hiring solutions business recognized for breadth of solutions, strong technology stack TROY, Mich., July 02, 2025 (GLOBE NEWSWIRE) -- KellyOCG® + Sevenstep, the permanent hiring solutions business of leading specialty talent solutions provider Kelly (Nasdaq: KELYA, KELYB), has been named a Leader and Star Performer on Everest Group's 2025 Recruitment Process Outsourcing (RPO) Services PEAK Matrix® Assessment – Global. The recognition comes just months after the formal integration of KellyOCG's RPO specialty and Motion Recruitment Partners' talent acquisition brand, Sevenstep. Everest Group's PEAK Matrix® provides an objective, data-driven assessment of global RPO providers based on their market impact, vision and capability. Providers are assessed in seven categories: market adoption, portfolio mix, value delivered, scope of service offerings, innovation and investments, delivery footprint, and vision and strategy. They are ranked as Leaders, Major Contenders or Aspirants. Star Performers are identified based on year-over-year performance movement on the PEAK Matrix®. KellyOCG + Sevenstep's leadership position among RPO providers reflects the company's global footprint – now expanded to 71 countries with 33 in-country teams – and its end-to-end talent acquisition capabilities, encompassing enterprise and project RPO, sourcing for niche roles, executive search, consulting, advanced data and predictive analytics technology, and total talent management. These capabilities are delivered through end-to-end and modular solutions shaped to align and evolve with each client's needs and challenges. 'The post-merger entity of KellyOCG + Sevenstep has created a strong RPO value proposition and portfolio,' Sailesh Hota, practice director at Everest Group, said. 'It has experience in catering to most major industries and supports hiring across both high-volume and specialized white-collar roles. This breadth is well complemented by a strong technology stack which combines Sevenstep's Sevayo® Insights and KellyOCG's Helix platforms. All of these capabilities combined with advisory support and value-added services have contributed to its positioning as a Leader and Star Performer on Everest Group's RPO Services PEAK Matrix® Assessment 2025 – Global." 'Being named an RPO Leader and Star Performer by Everest Group validates the power of our combined capabilities at KellyOCG + Sevenstep,' said Amy Bush, RPO president at KellyOCG + Sevenstep. 'Together, we deliver the scale, speed and strategic expertise that global organizations need to win talent in any market. With flexible, modular solutions and a relentless focus on outcomes, we help our clients build agile, high-performing talent functions that are truly ready for anything.' About KellyOCG® + Sevenstep KellyOCG + Sevenstep is a leading permanent hiring solutions provider and part of Kelly's outsourced workforce solutions business line that spans all facets of the employee and contingent workforce. Kelly connects companies with the talent they need to fuel and grow their business through recruitment process outsourcing (RPO), managed services provider (MSP), total talent management solutions and consulting. KellyOCG + Sevenstep combines decades of people industry experience and expertise with a continued investment in technology to produce world-class programs that meet an organization's unique workforce needs. Learn more at and About Everest GroupEverest Group is a leading global research firm helping business leaders make confident decisions. Everest Group's PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth content at DisclaimerLicensed extracts taken from Everest Group's PEAK Matrix® Reports, may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group's PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group's analysts and included in Everest Group's PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports. Media ContactChristian This press release was published by a CLEAR® Verified in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ('Nutriband' or the 'Company') announced today that its Board of Directors has approved and declared a 25% preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company's AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual basis as decided by the board of Directors. "Our core goal is to continue to create value for our shareholders particularly as we near closer to the commercialization of AVERSA fentanyl. We recently highlighted our Commercialization manufacturing process scale up with Kindeva and we are now laser focused on finalizing our development pathway to FDA approval," said Gareth Sheridan, CEO. About AVERSA™ Abuse-Deterrent Transdermal Technology Nutriband's AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia. About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. The Company's website is Any material contained in or derived from the Company's websites or any other website is not part of this press release. Forward-Looking Statements Certain statements contained in this press release, including, without limitation, statements containing the words ''believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company's business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form S-1, Forms 10-K's and Forms 10-Q's, and the Company's other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof. Contact Information: Nutriband Inc. Phone: 407-377-6695 Email: info@ SOURCE: Nutriband Inc.
